This independent lab test by Liquilabs confirms Retatrutide 10mg from Particle Peptides at >99.8% purity. The analysis was conducted on March 2, 2026, with batch number 2026302.
Retatrutide is a triple GIP/GLP-1/GCG receptor agonist researched for its potential role in metabolic regulation, weight management, and glycemic control. A purity level exceeding 99.8% indicates pharmaceutical-grade synthesis with minimal impurities. Endotoxin levels tested below 0.001 EU/mg, with no detected microbial or mold contamination, confirming safety for research use.
The full certificate of analysis is available from Liquilabs.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.